Agasthi P, Lee JZ, Amin M, Al-Saffar F, Goel V, Tseng A et al. Catheter ablation for treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: A systematic review and meta-analysis. J Arrhythm 2019; 35(2): 171-181.
Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ). Leitfaden: Orale Antikoagulation bei nicht valvulärem Vorhofflimmern. Empfehlungen zum Einsatz der direkten oralen Antikoagulanzien Dabigatran (Pradaxa®), Apixaban (Eliquis®), Edoxaban (Lixiana®) und Rivaroxaban (Xarelto®). 11.2019.
Asad ZU, Yousif A, Khan MS, Al-Khatib SM, Stavrakis S. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ Arrhythm Electrophysiol 2019; 12(9): e007414.
Briceño DF, Markman TM, Lupercio F, Romero J, Liang JJ, Villablanca PA et al. Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials. J Interv Card Electrophysiol 2018; 53(1): 19-29.
Clarkesmith DE, Lip GY, Lane DA. Patients'experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. Thromb Res 2017; 153: 19-27.
European Society of Cardiology (ESC), Deutsche Gesellschaft für Kardiologie (DGK). Management von Vorhofflimmern. Version 2016. (ESC Pocket-Guidelines).
Khan SU, Rahman H, Talluri S, Kaluski E. The Clinical Benefits and Mortality Reduction Associated With Catheter Ablation in Subjects With Atrial Fibrillation: A Systematic Review and Meta-Analysis. JACC Clin Electrophysiol 2018; 4(5): 626-635.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016; 50(5): e1-e88.
National Institute for Health and Care Excellence (NICE). Atrial Fibrillation: the management of atrial fibrillation. 12.2019. (National Clinical Guidelines; Band CG180).
Risom SS, Zwisler AD, Johansen PP, Sibilitz KL, Lindschou J, Gluud C et al. Exercise-based cardiac rehabilitation for adults with atrial fibrillation. Cochrane Database Syst Rev 2017; (2): CD011197.
Rush KL, Hatt L, Shay M, Gorman N, Laberge CG, Reid RC et al. The Stressors and Coping Strategies of Older Adults With Persistent Atrial Fibrillation Prior to and Following Direct Current Cardioversion. J Appl Gerontol 2017; 36(9): 1145-1165.
Salmasi S, Kwan L, MacGillivray J, Bansback N, De Vera MA, Barry AR et al. Assessment of atrial fibrillation patients'education needs from patient and clinician perspectives: A qualitative descriptive study. Thromb Res 2019; 173: 109-116.
Sethi NJ, Feinberg J, Nielsen EE, Safi S, Gluud C, Jakobsen JC. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and Trial Sequential Analysis. PLoS One 2017; 12(10): e0186856.
Smart NA, King N, Lambert JD, Pearson MJ, Campbell JL, Risom SS et al. Exercise-based cardiac rehabilitation improves exercise capacity and health-related quality of life in people with atrial fibrillation: a systematic review and meta-analysis of randomised and non-randomised trials. Open Heart 2018; 5(2): e000880.
Turagam MK, Garg J, Whang W, Sartori S, Koruth JS, Miller MA et al. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials. Ann Intern Med 2019; 170(1): 41-50.
Virk SA, Bennett RG, Chow C, Sanders P, Kalman JM, Thomas S et al. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients With Heart Failure: A Meta-Analysis of Randomised Controlled Trials. Heart Lung Circ 2019; 28(5): 707-718.
Voskoboinik A, Kalman JM, De Silva A, Nicholls T, Costello B, Nanayakkara S et al. Alcohol Abstinence in Drinkers with Atrial Fibrillation. N Engl J Med 2020; 382(1): 20-28.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.